Automated dose-response analysis of the relative hepatic gene expression potency of TCDF in C57BL/6 mice

Toxicological Sciences

Volumn 112, Issue 1, 2009, Pages 221-228

  Burgoon, Lyle D ^a,b   Ding, Qi ^a,b   N'jai, Alhaji ^a,b   Dere, Ed ^a,b   Burg, Ashley R ^a,b   Rowlands, J Craig ^c   Budinsky, Robert A ^c   Stebbins, Kenneth E ^c   Zacharewski, Tim R ^a,b  

^a Michigan State University   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c DOW CHEMICAL COMPANY   (United States)

Author keywords

Dose response; Liver; Microarray; Mouse; TCDD; TCDF; TEF; Temporal

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 2,3,7,8 TETRACHLORODIBENZOFURAN; ETHOXYRESORUFIN DEETHYLASE; SESAME SEED OIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; DOSE RESPONSE; EXPERIMENTAL MOUSE; FEEDING; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; LIVER TOXICITY; LIVER WEIGHT; MOUSE; NONHUMAN; TISSUE LEVEL; WORLD HEALTH ORGANIZATION;

ANIMALS; AUTOMATION; BENZOFURANS; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION PROFILING; LIVER; MICE; MICE, INBRED C57BL; ORGAN SIZE; POLYMERASE CHAIN REACTION; TETRACHLORODIBENZODIOXIN;

MUS; SESAMUM INDICUM;

EID: 71049154053     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfp180     Document Type: Article

References (28)

1. Boverhof, D. R., Burgoon, L. D., Tashiro, C., Chittim, B., Harkema, J. R., Jump, D. B., and Zacharewski, T. R. (2005). Temporal and dose-dependent hepatic gene expression patterns in mice provide new insights into TCDD-mediated hepatotoxicity. Toxicol. Sci. 85 1048-1063.
2. Boverhof, D. R., Burgoon, L. D., Tashiro, C., Sharratt, B., Chittim, B., Harkema, J. R., Mendrick, D. L., and Zacharewski, T. R. (2006). Comparative toxicogenomic analysis of the hepatotoxic effects of TCDD in Sprague Dawley rats and C57BL/6 mice. Toxicol. Sci. 94, 398-416.
3. Budinsky, R. A., Rowlands, J. C., Casteel, S., Fent, G., Cushing, C. A., Newsted, J., Giesy, J. P., Ruby, M. V., and Aylward, L. L. (2008). A pilot study of oral bioavailability of dioxins and furans from contaminated soils: Impact of differential hepatic enzyme activity and species differences. Chemosphere 70, 1774-1786.
4. Burgoon, L. D., Boutros, P. C., Dere, E., and Zacharewski, T. R. (2006). dbZach: A MIAME-compliant toxicogenomic supportive relational database. Toxicol. Sci. 90, 558-568.
5. Burgoon, L. D., and Zacharewski, T. R. (2007). dbZach toxicogenomic information management system. Pharmacogenomics 8, 287-291.
6. Burgoon, L. D., and Zacharewski, T. R. (2008). Automated quantitative dose-response modeling and point of departure determination for large toxicogenomic and high-throughput screening data sets. Toxicol. Sci. 104, 412-418.
7. DeVito, M. J., and Birnbaum, L. S. (1995). The importance of pharmacokinetics in determining the relative potency of 2,3,7,8-tetrachlorodibenzo-pdioxin and 2,3,7,8-tetrachlorodibenzofuran. Fundam. Appl. Toxicol. 24, 145-148.
8. Diliberto, J. J., Akubue, P. I., Luebke, R. W., and Birnbaum, L. S. (1995). Dose-response relationships of tissue distribution and induction of CYP1A1 and CYP1A2 enzymatic activities following acute exposure to 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD) in mice. Toxicol. Appl. Pharmacol. 130, 197-208.
9. Diliberto, J. J., DeVito, M. J., Ross, D. G., and Birnbaum, L. S. (2001). Subchronic exposure of [3H]- 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in female B6C3F1 mice: Relationship of steady-state levels to disposition and metabolism. Toxicol. Sci. 61, 241-255.
10. Eckel, J. E., Gennings, C., Chinchilli, V. M., Burgoon, L. D., and Zacharewski, T. R. (2004). Empirical bayes gene screening tool for timecourse or dose-response microarray data. J. Biopharm. Stat. 14, 647-670.
11. Eckel, J. E., Gennings, C., Therneau, T. M., Burgoon, L. D., Boverhof, D. R., and Zacharewski, T. R. (2005). Normalization of two-channel microarray experiments: A semiparametric approach. Bioinformatics 21, 1078-1083.
12. Fletcher, N., Hanberg, A., and Hakansson, H. (2001). Hepatic vitamin a depletion is a sensitive marker of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure in four rodent species. Toxicol. Sci. 62, 166-175.
13. Hamm, J. T., Chen, C. Y., and Birnbaum, L. S. (2003). A mixture of dioxins, furans, and non-ortho PCBs based upon consensus toxic equivalency factors produces dioxin-like reproductive effects. Toxicol. Sci. 74, 182-191.
14. Haws, L. C., Su, S. H., Harris, M., Devito, M. J., Walker, N. J., Farland, W. H., Finley, B., and Birnbaum, L. S. (2006). Development of a refined database of mammalian relative potency estimates for dioxin-like compounds. Toxicol. Sci. 89, 4-30.
15. Kopec, A. K., Boverhof, D. R., Burgoon, L. D., Ibrahim-Aibo, D., Harkema, J. R., Tashiro, C., Chittim, B., and Zacharewski, T. R. (2008). Comparative toxicogenomic examination of the hepatic effects of PCB126 and TCDD in immature, ovariectomized C57BL/6 mice. Toxicol. Sci. 102, 61-75.
16. Mason, G., and Safe, S. (1986). Synthesis, biologic and toxic effects of the major 2,3,7,8-tetrachlorodibenzo-p-dioxin metabolites in the rat. Toxicology 41, 153-159.
17. Moore, J. N., Newsted, J. L., Hecker, M., Zwiernik, M. J., Fitzgerald, S. D., Kay, D. P., Zhang, X., Higley, E. B., Aylward, L. L., Beckett, K. J., et al. (2009). Hepatic P450 enzyme activity, tissue morphology and histology of mink (Mustela vison) exposed to polychlorinated dibenzofurans. Arch. Environ. Contam. Toxicol. 57, 416-425; doi:10.1007/s00244-008-9241-3.
18. N'Jai, A., Boverhof, D. R., Dere, E., Burgoon, L. D., Tan, Y. S., Rowlands, J. C., Budinsky, R. A., Stebbins, K. E., and Zacharewski, T. R. (2008). Comparative temporal toxicogenomic analysis of TCDD- and TCDF-mediated hepatic effects in immature female C57BL/6 mice. Toxicol. Sci. 103, 285-297.
19. Poland, A., and Glover, E. (1973). Chlorinated dibenzo-p-dioxins: Potent inducers of delta-aminolevulinic acid synthetase and aryl hydrocarbon hydroxylase. II. A study of the structure-activity relationship. Mol. Pharmacol. 9, 736-747.
20. Safe, S. (1997). Limitations of the toxic equivalency factor approach for risk assessment of TCDD and related compounds. Teratog. Carcinog. Mutagen. 17, 285-304.
21. Safe, S. (2001). Molecular biology of the Ah receptor and its role in carcinogenesis. Toxicol. Lett. 120, 1-7.
22. Safe, S., Robertson, L. W., Safe, L., Parkinson, A., Bandiera, S., Sawyer, T., and Campbell, M. A. (1982). Halogenated biphenyls: Molecular toxicology. Can. J. Physiol. Pharmacol. 60, 1057-1064.
23. Starr, T. B., Greenlee, W. F., Neal, R. A., Poland, A., and Sutter, T. R. (1999). The trouble with TEFs. Environ. Health. Perspect. 107, A492-A493.
24. Taylor, M. J., Lucier, G. W., Mahler, J. F., Thompson, M., Lockhart, A. C., and Clark, G. C. (1992). Inhibition of acute TCDD toxicity by treatment with anti-tumor necrosis factor antibody or dexamethasone. Toxicol. Appl. Pharmacol. 117, 126-132.
25. Thomas, R. S., Allen, B. C., Nong, A., Yang, L., Bermudez, E., Clewell, H. J., 3rd., and Andersen, M. E. (2007). A method to integrate benchmark dose estimates with genomic data to assess the functional effects of chemical exposure. Toxicol. Sci. 98, 240-248.
26. Van den Berg, M., Birnbaum, L., Bosveld, A. T., Brunstrom, B., Cook, P., Feeley, M., Giesy, J. P., Hanberg, A., Hasegawa, R., Kennedy, S. W., et al. (1998). Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ. Health. Perspect. 106 775-792.
27. Van den Berg, M., Birnbaum, L. S., Denison, M., De Vito, M., Farland, W., Feeley, M., Fiedler, H., Hakansson, H., Hanberg, A., Haws, L., et al. (2006). The 2005 World Health Organization reevaluation of human and Mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol Sci. 93, 223-241.
28. Zwiernik, M. J., Bursian, S., Aylward, L. L., Kay, D. P., Moore, J., Rowlands, C., Woodburn, K., Shotwell, M., Khim, J. S., Giesy, J. P., et al. (2008). Toxicokinetics of 2,3,7,8-TCDF and 2,3,4,7,8-PeCDF in mink (Mustela vison) at ecologically relevant exposures. Toxicol. Sci. 105, 33-43.